(VPHM) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
February 09, 2010
(Stock Blog Hub,
12/4/08)
ViroPharma Inc. (VPHM) is seeing record sales of its big drug Vancocin which is adding to its already sizable cash hoard. Sales are expected to grow 159.26%. VPHM is an attractive...(read more)
(Blogvesting,
7/29/08)
Viropharma recently acquired Lev Pharmaceuticals for $443 million ($2.75 per Lev share), primarily for its orphan drug Cinryze, which is used to treat HAE (hereditary angioedema). There are additional payouts of...(read more)
(Blogvesting,
11/11/07)
Generally, I tend to stay away from pharmaceuticals, because I find it difficult to accurately handicap the odds of drug trials. However, I have decided to make an exception in this case, because...(read more)
ViroPharma (VPHM) Company Overview
There is no analysis for VPHM yet. But you can go to Wikinvest to help create one!
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes. By accessing this page, you agree to the following terms and conditions. Conference calls info supplied by OpenCompany Fundamental data supplied by Morningstar Stock quotes supplied by Telekurs USA |
|
